Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from AVITA Medical

Avita Medical Q1 Earnings Call Highlights

Avita Medical (NASDAQ:RCEL) reported first-quarter 2026 revenue growth and reaffirmed its full-year outlook as management said reimbursement conditions for its RECELL product are normalizing and demand patterns are becoming more consistent. The regenerative medicine company posted first-quarter rev

MarketBeat · May 15

Top 3 Health Care Stocks You'll Regret Missing This Quarter

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Benzinga · Jun 26, 2025

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has accepted the Menarini Group and Radius Health’s (NASDAQ:RDUS), New Drug Application (NDA) for elacestrant for patients with ER+/HER2- advanced or metastatic breast cancer. The agency has granted Priority Review designation and assigned a target action date of February 17, 2023. Radius Health…

Benzinga · Aug 11, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

AVITA Medical: Q3 Earnings Insights

AVITA Medical (NASDAQ:RCEL) reported its Q3 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings AVITA Medical beat estimated earnings by 5.0%, reporting an EPS of $-0.38 versus an estimate of $-0.4.

Benzinga · May 12, 2022

AVITA Medical Modifies BARDA Contract For RECELL System In Soft Tissue Reconstruction

Biomedical Advanced Research and Development Authority (BARDA) has

Benzinga · Mar 22, 2022

AVITA Medical Inks Supply Pact With Premier For RECELL System

AVITA Medical Inc (NASDAQ:RCEL) has been awarded a group purchasing agreement with Premier Inc (NASDAQ:PINC) The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the RECELL System for the treatment of adult and pediatric patients with severe burns. The RECELL System is a…

Benzinga · Mar 3, 2022

AVITA Medical: Q2 Earnings Insights

AVITA Medical (NASDAQ:RCEL) reported its Q2 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga · Feb 28, 2022

Read news from The Economist, FT, and more,
with one subscription

Coverage From

Organisations

Food and Drug Administration

Catalyst Pharmaceuticals

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.